APA (7th ed.) Citation

C, Y., FZ, Z., EV, C., LLH, L., E, S., JS, W., . . . N, K. (2021). The Efficacy of Transdermal Rivastigmine in Mild to Moderate Alzheimer’s Disease with Concomitant Small Vessel Cerebrovascular Disease: Findings from an Open-Label Study. Dove Medical Press.

Chicago Style (17th ed.) Citation

C, Yatawara, Zailan FZ, Chua EV, Lim LLH, Silva E, Wang JS, Ng A, Ng KP, and Kandiah N. The Efficacy of Transdermal Rivastigmine in Mild to Moderate Alzheimer’s Disease with Concomitant Small Vessel Cerebrovascular Disease: Findings from an Open-Label Study. Dove Medical Press, 2021.

MLA (8th ed.) Citation

C, Yatawara, et al. The Efficacy of Transdermal Rivastigmine in Mild to Moderate Alzheimer’s Disease with Concomitant Small Vessel Cerebrovascular Disease: Findings from an Open-Label Study. Dove Medical Press, 2021.